In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators
暂无分享,去创建一个
[1] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[2] B. Silverman,et al. Density estimation in action , 1986 .
[3] Hong‐Tai Chang,et al. Effect of the anti-breast cancer drug tamoxifen on Ca(2+) movement in human osteosarcoma cells. , 2002, Pharmacology & toxicology.
[4] Aniko Simon,et al. eHiTS: a new fast, exhaustive flexible ligand docking system. , 2007, Journal of molecular graphics & modelling.
[5] G. Klebe,et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. , 2004, Journal of medicinal chemistry.
[6] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[7] A. Fliri,et al. Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.
[8] Hong‐Tai Chang,et al. The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells , 2003, Archives of Toxicology.
[9] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Ammirati,et al. The 2.0 Å crystal structure of the ERα ligand‐binding domain complexed with lasofoxifene , 2007, Protein science : a publication of the Protein Society.
[11] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[12] P E Bourne,et al. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. , 1998, Protein engineering.
[13] Philip E. Bourne,et al. Functional Coverage of the Human Genome by Existing Structures, Structural Genomics Targets, and Homology Models , 2005, PLoS Comput. Biol..
[14] S. Ekins. Predicting undesirable drug interactions with promiscuous proteins in silico. , 2004, Drug discovery today.
[15] R. Cenedella,et al. Diethylstilbestrol increases intracellular calcium in lens epithelial cells , 2005, Pflügers Archiv.
[16] E. Winer,et al. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. , 1992, Journal of the National Cancer Institute.
[17] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[18] M. Singh. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone‐related clinical disorders , 2001, Medicinal research reviews.
[19] B. Silverman. Density estimation for statistics and data analysis , 1986 .
[20] Russell L. Marsden,et al. Progress of structural genomics initiatives: an analysis of solved target structures. , 2005, Journal of molecular biology.
[21] Ruili Huang,et al. Evaluating Chemical Structure Similarity as an Indicator of Cellular Growth Inhibition , 2006, J. Chem. Inf. Model..
[22] Sandrine Gerber-Lemaire,et al. Evaluation of docking programs for predicting binding of Golgi α‐mannosidase II inhibitors: A comparison with crystallography , 2007, Proteins.
[23] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[24] Hiromi Nomura,et al. Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues , 2004, Nature.
[25] Y. Sugita,et al. Structural role of countertransport revealed in Ca(2+) pump crystal structure in the absence of Ca(2+). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Paterson,et al. Regulation of sarco/endoplasmic Ca2+ -ATPase expression by calcium in human lens cells. , 2002, Experimental eye research.
[27] Y. Sugita,et al. Inaugural Article: Structural role of countertransport revealed in Ca2+ pump crystal structure in the absence of Ca2+. , 2005 .
[28] S. J. Campbell,et al. Ligand binding: functional site location, similarity and docking. , 2003, Current opinion in structural biology.
[29] C. Paterson,et al. Regulation of sarco/endoplasmic and plasma membrane calcium ATPase gene expression by calcium in cultured human lens epithelial cells. , 2007, Cell calcium.
[30] Qing Zhang,et al. The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema , 2004, Nucleic Acids Res..
[31] J. Davies,et al. Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.
[32] V. Jordan. SERMs: meeting the promise of multifunctional medicines. , 2007, Journal of the National Cancer Institute.
[33] J. Lamerdin,et al. Identifying off-target effects and hidden phenotypes of drugs in human cells , 2006, Nature chemical biology.
[34] Nathan A. Baker,et al. Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Bojanic,et al. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.
[36] E. Petricoin,et al. Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.
[37] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[38] Z. Deng,et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.
[39] Z. Xiang,et al. Advances in homology protein structure modeling. , 2006, Current protein & peptide science.
[40] D. J. Price,et al. Assessing scoring functions for protein-ligand interactions. , 2004, Journal of medicinal chemistry.
[41] Ajay N. Jain. Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search , 2007, J. Comput. Aided Mol. Des..
[42] Patricia Williams,et al. Origins, practices and future of safety pharmacology. , 2004, Journal of pharmacological and toxicological methods.
[43] T. Klabunde,et al. GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR‐Mediated Side Effects , 2005, Chembiochem : a European journal of chemical biology.
[44] A. Fliri,et al. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.
[45] Renxiao Wang,et al. Comparative evaluation of 11 scoring functions for molecular docking. , 2003, Journal of medicinal chemistry.
[46] J. Custódio,et al. The effect of the anticancer drugs tamoxifen and hydroxytamoxifen on the calcium pump of isolated sarcoplasmic reticulum vesicles. , 1996, Toxicology in vitro : an international journal published in association with BIBRA.
[47] M. Gorin,et al. Tamoxifen-associated eye disease. A review. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Marilyn E. Miller,et al. Influence of hormones on platelet intracellular calcium. , 1995, Thrombosis research.
[49] Adrian H Elcock,et al. Progress toward virtual screening for drug side effects , 2002, Proteins.
[50] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[51] C. A. Ward,et al. Tamoxifen inhibits Ca2+ uptake by the cardiac sarcoplasmic reticulum , 2000, Pflügers Archiv.
[52] M. Chow,et al. Safety and efficacy of antiestrogens for prevention of breast cancer. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[53] Didier Rognan,et al. Comparative evaluation of eight docking tools for docking and virtual screening accuracy , 2004, Proteins.
[54] Yi Wang,et al. In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction. , 2006, Toxicology letters.
[55] Tepmanas Bupha-Intr,et al. Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. , 2006, American journal of physiology. Heart and circulatory physiology.
[56] Philip Lijnzaad,et al. The Ensembl genome database project , 2002, Nucleic Acids Res..
[57] C. A. Ward,et al. Effects of Phytoestrogens on Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2a and Ca2+ Uptake into Cardiac Sarcoplasmic Reticulum , 2006, Journal of Pharmacology and Experimental Therapeutics.
[58] Bernard W. Silverman,et al. Density Estimation for Statistics and Data Analysis , 1987 .
[59] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[60] K. C. Lee,et al. Dual effect of tamoxifen, an anti-breast-cancer drug, on intracellular Ca(2+) and cytotoxicity in intact cells. , 2000, Toxicology and applied pharmacology.
[61] M. E. Kargacin,et al. Effects of anti‐oestrogens and β‐estradiol on calcium uptake by cardiac sarcoplasmic reticulum , 2001, British journal of pharmacology.
[62] Philip E. Bourne,et al. A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites , 2007, BMC Bioinformatics.